Novo Nordisk A/S purchases B shares worth DKK 1,038 million from Novo Holdings A/S under the 2018 share repurchase programme


 

Bagsværd, Denmark, 4 May 2018 - Novo Nordisk A/S has today entered into an agreement to purchase 3,415,895 B shares (nominal DKK 0.20) of a value of DKK 1,038 million from Novo Holdings A/S. This transaction is part of Novo Nordisk's 2018 share repurchase programme of up to a total of DKK 14.0 billion to be executed during a 12 months period beginning 1 February 2018. The transaction price is DKK 303.83 per share and has been calculated as the volume weighted average market price from 2 May to 4 May 2018 in the open window following the announcement of Novo Nordisk A/S' quarterly financial results.

Prior to the sale of B shares, Novo Holdings A/S' ownership of Novo Nordisk A/S was 28.5% of the share capital and 76.2% of the votes. Following the transaction, Novo Holdings A/S owns 537,436,000 A shares of DKK 0.20 and 157,310,695 B shares of DKK 0.20, corresponding to 28.4% of the capital and 76.2% of the votes in Novo Nordisk A/S.

The transaction is in line with the announcement on 2 May 2018 that Novo Holdings A/S intends to maintain its ownership of Novo Nordisk A/S' share capital around 28%.

Transactions related to Novo Nordisk A/S' incentive programmes have resulted in a net transfer from Novo Nordisk of 3,155 B shares of DKK 0.20 in the period from 2 May 2018 to 4 May 2018. Novo Nordisk A/S owns a total of 24,743,093 B shares of DKK 0.20, corresponding to 1.0% of the share capital, as treasury shares including this transaction. The total amount of A and B shares in the company is 2,450,000,000 of DKK 0.20 including treasury shares.

Further information

Novo Holdings Communication    
Christian Mostrup Scheel +45 3067 4805 cims@novo.dk
     
Novo Nordisk Media:    
Katrine Sperling +45 3079 6718 krsp@novonordisk.com
Ken Inchausti (US) +1 609 786 8316 kiau@novonordisk.com
     
Novo Nordisk Investors:    
Peter Hugreffe Ankersen +45 3075 9085 phak@novonordisk.com
Anders Mikkelsen +45 3079 4461 armk@novonordisk.com
Christina Kjær +45 3079 3009 cnje@novonordisk.com

 Company announcement No 39/2018


Attachments

PR180504_NHAS_buyback_UK